Detalhe da pesquisa
1.
Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAFV600 mutation-positive melanoma.
Ann Oncol
; 33(5): 544-555, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35131452
2.
Cobimetinib plus atezolizumab in BRAFV600 wild-type melanoma: primary results from the randomized phase III IMspire170 study.
Ann Oncol
; 32(3): 384-394, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33309774
3.
Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv600 mutation-positive melanoma receiving adjuvant vemurafenib.
Ann Oncol
; 31(1): 153-159, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31912791
4.
[Impact of СD8/FoxP3 T lymphocyte ratio in the peritumoral area of primary cutaneous melanoma on the prognosis of the disease]. / Vliyanie sootnosheniya CD8/FoxP3 T-limfotsitov v peritumoral'noi zone pervichnoi melanomy kozhi na prognoz techeniya zabolevaniya.
Arkh Patol
; 78(4): 27-31, 2016.
Artigo
em Russo
| MEDLINE | ID: mdl-27600779
5.
[ Spectrum of oncogene mutations is different in melanoma subtypes].
Mol Biol (Mosk)
; 49(6): 1022-9, 2015.
Artigo
em Russo
| MEDLINE | ID: mdl-26710785
6.
Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine.
Ann Oncol
; 25(7): 1428-1436, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24769640
7.
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study.
Ann Oncol
; 25(3): 700-706, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24504441
8.
Phase I-II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma.
Br J Cancer
; 109(6): 1451-9, 2013 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23989947
9.
Somatostatin receptor type 2 expression in Merkel cell carcinoma as a prognostic factor.
J Eur Acad Dermatol Venereol
; 32(6): e236-e237, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29265481
10.
[Use of sunitinib in metastatic renal cell carcinoma patients with poor prognosis].
Vopr Onkol
; 57(1): 50-4, 2011.
Artigo
em Russo
| MEDLINE | ID: mdl-21598708
11.
Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trial.
Nat Med
; 27(10): 1789-1796, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34608333
12.
Use of recombinant interleukin-2 for intrapleural therapy of tumor-associated pleurisy.
Bull Exp Biol Med
; 148(5): 794-6, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20396794
13.
[Cancer vaccinotherapy: from the experiment to clinical application].
Vestn Ross Akad Med Nauk
; (10): 46-8, 2007.
Artigo
em Russo
| MEDLINE | ID: mdl-18050681
14.
[Adoptive immunotherapy of malignancies].
Vestn Ross Akad Med Nauk
; (11): 9-15, 2007.
Artigo
em Russo
| MEDLINE | ID: mdl-18080522
15.
FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma.
Clin Transl Oncol
; 19(2): 265-268, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27379982
16.
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.
Eur J Cancer
; 75: 313-322, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28264791
17.
[Use of docetaxel in treatment of squamous-cell carcinoma of head and neck].
Vopr Onkol
; 57(4): 421-6, 2011.
Artigo
em Russo
| MEDLINE | ID: mdl-22191228
18.
Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study.
ESMO Open
; 1(4): e000068, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27843625
19.
[Melanoma cell lines as the basis for antitumor vaccine preparation].
Vestn Ross Akad Med Nauk
; (7): 37-40, 2005.
Artigo
em Russo
| MEDLINE | ID: mdl-16107020
20.
Enhanced expression of 1p32 and 1p22 fragile sites in lymphocytes in cutaneous malignant melanomas.
Cancer Genet Cytogenet
; 58(1): 24-8, 1992 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-1530833